FOLD Financial Facts
Loss from operations: -44.94MResearch and development: 32.46M
See Full Income Statement
Other non-current assets: 1.79M
Total stockholders' equity: 336.56M
See Full Balance Sheet
Amicus Therapeutics, Inc. (FOLD) Earnings
|
Expand Research on FOLD
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +314.8% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/13/26  |
Q126 | N/A | $0.04 | N/A | N/A | $162.51M | N/A | N/A | N/A | ||
| 2/20/26 |
Q425 | N/A | $0.07 | N/A | N/A | $179.77M | N/A | N/A | N/A | ||
| 2/19/26 |
Q425 | N/A | $0.07 | N/A | N/A | $179.77M | N/A | N/A | N/A | ||
| 11/4/25 | Q325 | $0.06 | $0.03 | +$0.03 | $169.06M | $165.44M | N/A |  | | Details | |
| 7/31/25 | Q225 | $0.01 | -$0.11 | +$0.12 | $154.7M | $146.73M | N/A | | | Details | |
| 5/1/25 | Q125 | $0.03 | -$0.02 | +$0.05 | $125.25M | $136.65M | N/A | | | Details | |
| 2/19/25 | Q424 | $0.09 | $0.01 | +$0.08 | N/A | $146.97M | N/A | | | Details | |
| 11/6/24 | Q324 | $0.10 | $0.00 | +$0.10 | $141.52M | $134.93M | N/A | | | Details |
